Skip to content
Home/Companies/Pharma/MyCural Therapeutics AB

MyCural Therapeutics AB

Pharma·Sweden·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns MyCural Therapeutics AB?

MyCural Therapeutics AB is a Swedish Pharma company, currently owned by SLU Holding since 2022.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
SLU Holding
Investor
SLU Holding
SLU Holding · 1995 · VC

Key facts

HQSweden
SectorPharma
StatusActive

More from SLU Holding

Other portfolio companies in the same fund.

Traktorarvid AB
Active
AgTechSweden· 2024
Artroa AB
Active
PharmaSweden· 2023
SGPTH Life Sciences AB
Active
MedTechSweden· 2023
Greensway Digital AB
Active
ClimateTechSweden· 2022
NitroCapt AB
Active
ClimateTechSweden· 2022
Alertix Veterinary Diagnostics AB
Active
MedTechSweden· 2021

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns MyCural Therapeutics AB?

MyCural Therapeutics AB is currently owned by SLU Holding, through SLU Holding, since 2022.

When did SLU Holding acquire MyCural Therapeutics AB?

SLU Holding acquired MyCural Therapeutics AB in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue